• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电疗的晚期并发症 - 经静脉心内膜导线取出适应证的临床分析:单中心经验。

Late complications of electrotherapy - a clinical analysis of indications for transvenous removal of endocardial leads: a single centre experience.

机构信息

Second Clinical Department of Cardiology, Regional District Hospital, Kielce, Poland.

出版信息

Kardiol Pol. 2013;71(4):366-72. doi: 10.5603/KP.2013.0064.

DOI:10.5603/KP.2013.0064
PMID:23788342
Abstract

BACKGROUND

Despite advances in electrotherapy, late complications constitute an increasing clinical and therapeutic problem. Transvenous lead extraction (TLE) is becoming a safe and effective approach to the treatment of such complications.

AIM

To assess indications for TLE and to evaluate safety and efficacy of TLE procedures.

METHODS

A retrospective clinical analysis of 100 patients with complications of electrotherapy admitted to a tertiary care centre in 2008-2011.

RESULTS

In 2008-2011, the number of electrotherapy complications increased markedly. The most frequent reason for TLE was lead dysfunction (62% of patients, including 31% with an implanted cardioverter-defibrillator [ICD] and 31% with a pacemaker [PM]). The most common type of lead dysfunction was conductor damage (38% of patients, including 23% with ICD, 15% with PM), followed by late myocardial perforation (14% of patients, including 7% with ICD, 7% with PM), abnormal course of the lead (7% of patients, including 1% with ICD, 6% with PM), and lead insulation failure (3% of patients). Other reasons for TLE were infectious complications (24% of patients, including 15% with PM pocket infection), venous insufficiency (17% of patients, including 10% in whom an indwelling lead was a direct obstacle to switching the pacing mode), and the need to switch the pacing mode (4% of patients). Procedural efficacy was 96% (lead fragments were left in place in 4% of patients). No significant clinical complications were observed in any of the patients in the periprocedural period.

CONCLUSIONS

Clinical manifestations of electrotherapy complications in the study group varied and included a relatively small number of infectious complications (24%) and a relatively large number of late myocardial perforations (14%). Efficacy and safety of the procedures were very high.

摘要

背景

尽管电疗技术不断进步,但迟发性并发症仍是日益严峻的临床和治疗问题。经静脉导线拔除术(TLE)已成为治疗此类并发症的安全有效方法。

目的

评估 TLE 的适应证,并评估 TLE 操作的安全性和有效性。

方法

对 2008 年至 2011 年期间在三级医疗中心因电疗并发症住院的 100 例患者进行回顾性临床分析。

结果

2008 年至 2011 年,电疗并发症数量显著增加。TLE 的最常见原因是导线功能障碍(62%的患者,包括 31%的植入式心脏转复除颤器[ICD]和 31%的起搏器[PM])。最常见的导线功能障碍类型是导体损坏(38%的患者,包括 23%的 ICD、15%的 PM),其次是迟发性心肌穿孔(14%的患者,包括 7%的 ICD、7%的 PM)、导线异常走行(7%的患者,包括 1%的 ICD、6%的 PM)和导线绝缘故障(3%的患者)。TLE 的其他原因包括感染性并发症(24%的患者,包括 15%的 PM 囊袋感染)、静脉功能不全(17%的患者,包括 10%的患者留置导线直接妨碍起搏模式转换)和需要转换起搏模式(4%的患者)。操作成功率为 96%(4%的患者有导线碎片残留)。围手术期内所有患者均未观察到明显的临床并发症。

结论

研究组电疗并发症的临床表现各不相同,包括相对较少的感染性并发症(24%)和较多的迟发性心肌穿孔(14%)。该操作的疗效和安全性非常高。

相似文献

1
Late complications of electrotherapy - a clinical analysis of indications for transvenous removal of endocardial leads: a single centre experience.电疗的晚期并发症 - 经静脉心内膜导线取出适应证的临床分析:单中心经验。
Kardiol Pol. 2013;71(4):366-72. doi: 10.5603/KP.2013.0064.
2
Safety and effectiveness of transvenous extraction of pacemaker and implantable cardioverter-defibrillator leads in patients under or over 80 years of age.经静脉取出起搏器和植入式心脏复律除颤器导线在 80 岁以下和 80 岁以上患者中的安全性和有效性。
Kardiol Pol. 2013;71(2):130-5. doi: 10.5603/KP.2013.0005.
3
Is the transvenous extraction of cardioverter-defibrillator leads more hazardous than that of pacemaker leads?经静脉取出心脏转复除颤器导线是否比取出起搏器导线更危险?
Kardiol Pol. 2010 Aug;68(8):884-90.
4
Complications of permanent cardiac pacing in patients with persistent left superior vena cava.永存左上腔静脉患者永久性心脏起搏的并发症
Cardiol J. 2014;21(2):128-37. doi: 10.5603/CJ.a2014.0006. Epub 2014 Feb 14.
5
[Extraction of chronically implanted transvenous pacing and defibrillator leads - cost analysis].[长期植入式经静脉起搏和除颤导线的拔除——成本分析]
Kardiol Pol. 2012;70(1):96-9.
6
Occurrence and extraction of implantable cardioverter-defibrillator leads with conductor externalization.可植入式心脏复律除颤器导线伴导体外置的发生与提取
Cardiol J. 2018;25(2):221-228. doi: 10.5603/CJ.a2017.0100. Epub 2017 Aug 25.
7
Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.经皮心内膜下心导管取出术在咨询下进行——比较 Riata、Sprint Fidelis 和未召回的植入式心脏复律除颤器导线。
Heart Rhythm. 2013 Oct;10(10):1444-50. doi: 10.1016/j.hrthm.2013.06.021. Epub 2013 Jun 28.
8
Lead-Dependent Infective Endocarditis: The Role of Factors Predisposing to Its Development in an Analysis of 414 Clinical Cases.铅依赖型感染性心内膜炎:在414例临床病例分析中易患因素对其发病的作用
Pacing Clin Electrophysiol. 2015 Jul;38(7):846-56. doi: 10.1111/pace.12615. Epub 2015 Mar 27.
9
The analysis of indications and early results of transvenous lead extraction in patients with a pacemaker, ICD and CRT - single-center experience.起搏器、植入式心律转复除颤器(ICD)和心脏再同步治疗(CRT)患者经静脉导线拔除的适应证分析及早期结果——单中心经验
Acta Cardiol. 2015 Dec;70(6):685-92. doi: 10.2143/AC.70.6.3120181.
10
Twenty-year experience of transvenous lead extraction at a single centre.单中心经静脉导线拔除术的20年经验。
Europace. 2014 Sep;16(9):1350-5. doi: 10.1093/europace/eut424. Epub 2014 Feb 19.

引用本文的文献

1
Complications of electrotherapy - the dark side of treatment with cardiac implantable electronic devices.电疗法的并发症——心脏植入式电子设备治疗的阴暗面。
Postepy Kardiol Interwencyjnej. 2018;14(1):15-25. doi: 10.5114/aic.2018.74351. Epub 2018 Mar 22.
2
Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive Patients.经静脉植入电极后发生的静脉狭窄:对212例连续患者的结局和危险因素的研究。
J Am Heart Assoc. 2015 Jul 31;4(8):e001878. doi: 10.1161/JAHA.115.001878.